alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                               .
                                                                               .
                                                                               .

                                                                     EXHIBIT 8.1

                                  SUBSIDIARIES

<TABLE>
<CAPTION>
                                                 Location and Country of
               Name                                    Incorporation
               ----                              -----------------------
<S>                                             <C>
BE Semiconductor Industries USA, Inc.           Londonderry, New Hampshire, USA
Fico B.V.                                       Duiven, the Netherlands
Fico Molding Systems B.V.                       Duiven, the Netherlands
Fico Trim & Form Integration Systems B.V.       Duiven, the Netherlands
Fico Tooling B.V.                               Duiven, the Netherlands
Fico Tooling Leshan Company Ltd.                Leshan, China
Fico Asia SDN. BHD.                             Shah Alam, Malaysia
Fico America Inc.                               Chandler, Arizona, USA
ASM Fico (F.E.) SDN. BHD.                       Shah Alam, Malaysia
Besi Korea Ltd.                                 Seoul, Korea
Fico Hong Kong Ltd.                             Hong Kong, China
Nihon Fico Ltd.                                 Tokyo, Japan
Fico Sales & Service Pte. Ltd.                  Singapore
Meco International B.V.                         Drunen, the Netherlands
Meco Equipment Engineers B.V.                   Drunen, the Netherlands
Besi Japan Co. Ltd.                             Tokyo, Japan
Meco Equipment Engineers Inc.                   Rock Hill, South Carolina, USA
Meco Equipment Engineers (Far East) Pte Ltd.    Singapore
Besi Die Handling Inc.                          Londonderry, New Hampshire, USA
</TABLE>
Exhibit


	
			
	
	 
	The Boeing Company
P.O. Box 3707
Seattle, WA  98124‐2207








SWA-PA-1810-LA-1501773


Southwest Airlines Co.
2702 Love Field Drive
P.O. Box 36611
Dallas, Texas 75235


	
		
	Subject:
	Cancelation of Option Aircraft






	
			
	Reference:
	a)
	Purchase Agreement No. 1810 (as amended, modified or supplemented from time to time, the Purchase Agreement) between The Boeing Company (Boeing) and Southwest Airlines Co. (Customer) relating to Model 737-7H4 aircraft (Aircraft)

	 
	b)
	Letter Agreement No. LA 1105884R1, titled Option Aircraft, dated December 5, 2014 (Option Letter Agreement)






This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement.  All terms used but not defined in this Letter Agreement will have the same meaning as in the Purchase Agreement.
	
		
	1.
	Cancelation of Option Aircraft.




By this Letter Agreement, the twelve (12) remaining 2016 Option Aircraft granted in the referenced Option Letter Agreement are hereby canceled, in accordance with the terms set forth in the Option Letter Agreement.
	
		
	2.
	Confidential Treatment




Customer understands and agrees that the information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. Customer agrees to limit the disclosure of such information to employees of Customer with a need to know the information for purposes of helping Customer perform Customer’s obligations under the Purchase Agreement and who understand they are not to disclose such information to any other person or entity. 


Very truly yours,
	
			
	THE BOEING COMPANY
	ACCEPTED AND AGREED TO this

	 
	Date: 7/6/2015

	/s/ Jon W. Lewis
	SOUTHWEST AIRLINES CO.

	 
	 

	By
	Jon W. Lewis
	By /s/ Chris Monroe

	 
	         Chris Monroe

	Its
	Attorney-In-Fact
	Its     VP, Treasurer









	
	
	July 2, 2015

	BOEING PROPRIETARY
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, November 01, 2017.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, November 01, 2017

The Court of Appeals hereby passes the following order

A18D0127. JENA DENNIS PINDER v. SAMUEL DWAYNE PINDER.

Upon consideration of the Application for Discretionary Appeal, it is ordered that it be 

hereby GRANTED. The Appellant may file a Notice of Appeal within 10 days of the date of 

this order. The Clerk of Superior Court is directed to include a copy of this order in the record 

transmitted to the Court of Appeals.

LC NUMBERS:

2014SUCV2405
Exhibit
      23





**CONSENT
      OF
      INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**














We
      hereby consent to the incorporation by reference in the Registration Statement
      on Form S-8 (Nos. 33-58396, 33-67218, 33-58797, 33-56721, 333-45402, and
      333-59722) of Stanley Furniture Company, Inc. of our report dated January 29,
      2007 relating to the financial statements, financial statement schedule,
      management’s assessment of the effectiveness of internal control over financial
      reporting and the effectiveness of internal control over financial reporting,
      which appears in this Form 10-K.










PricewaterhouseCoopers
      LLP


Richmond,
      Virginia





February
      5,
      2007
----

Exhibit 32.1

**CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

            In connection  with the Quarterly Report of Bellacasa Productions, Inc. (the "Company") on  Form 10-QSB for the three months ending September 30, 2002 as filed with the  Securities and Exchange Commission on the date hereof (the "Report"), I,  Richard Gagne, President, certify, pursuant to 18 U.S.C. Section  1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act  of 2002, that:

            (1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of  the Securities Exchange Act of 1934; and

            (2)   The information contained in the Report fairly presents, in all material respects,  the financial condition and result of operations of the Company.

Date: January 15, 2005

| /s/ Richard Gagne                                                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                    |
| Richard Gagne, President and Chief Executive Officer (Principal        Executive Officer) and Acting Chief Financial Officer (Principal Financial        Officer and Principal Accounting Officer) |
EXHIBIT 32.2

SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Gary S. Titus, Senior Vice President,
Finance and Chief Financial Officer, of SciClone Pharmaceuticals, Inc. (the Registrant), do hereby certify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on my
knowledge:



|(1) | the Quarterly Report on Form 10-Q of the Registrant, to which this certification is attached as an exhibit (the Report), fully complies with the
requirements of section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |  |  |                                                           
|------------------ |  |  |  | ----------------------------------------------------------
|Date: May 10, 2011 |  |  |  | /s/ Gary S. Titus                                         
|                   |  |  |  | Gary S. Titus                                             
|                   |  |  |  | Senior Vice President, Finance and Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been provided to SciClone Pharmaceuticals, Inc. and will be retained by SciClone Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its
staff upon request.
I 

111TH CONGRESS 

1ST SESSION H. R. 4386 

To amend title 10, United States Code, to require emergency contraception 

to be available at all military health care treatment facilities. 

IN THE HOUSE OF REPRESENTATIVES 

DECEMBER 16, 2009 

Mr. MICHAUD (for himself, Ms. TSONGAS, Ms. HARMAN, Mr. RYAN of Ohio, 

and Mrs. DAVIS of California) introduced the following bill; which was 

referred to the Committee on Armed Services 

A BILL 

To amend title 10, United States Code, to require emergency 

contraception to be available at all military health care 

treatment facilities. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Compassionate Care 

5 for Servicewomen Act’’. 


erowe on DSK5CLS3C1PROD with BILLS
2 

•HR 4386 IH

1 SEC. 2. REQUIREMENT TO MAKE AVAILABLE EMERGENCY 

2 CONTRACEPTION AT ALL MILITARY HEALTH 

3 CARE TREATMENT FACILITIES. 

4 Section 1074g(a) of title 10, United States Code, is 

5 amended by adding at the end the following new para6 graph: 

7 ‘‘(9)(A) Emergency contraception in drug form shall 

8 be included on the basic core formulary of the uniform 

9 formulary, notwithstanding any provision of law or regula10 tion requiring that only drugs ordered or prescribed by 

11 a physician (or other authorized provider) may be included 

12 in the uniform formulary. Emergency contraception in 

13 other-than-drug form may also be included on the basic 

14 core formulary, notwithstanding any such provision. 

15 ‘‘(B) Nothing in subparagraph (A) may be construed 

16 to require emergency contraception to be covered under 

17 the pharmacy benefits program. 

18 ‘‘(C) Notwithstanding paragraph (4), prior author19 ization shall not be required for emergency contraception. 

20 Nothing in the preceding sentence may be construed as 

21 waiving any provision of the Federal Food, Drug, and Cos22 metic Act (21 U.S.C. 301 et seq.) or any other provision 

23 of law administered by the Food and Drug Administra24 tion, including rules and orders of such Administration in 

25 effect at any time under such Act or other provisions of 

26 law. 


erowe on DSK5CLS3C1PROD with BILLS
3 

•HR 4386 IH

1 ‘‘(D) In this paragraph, the term ‘emergency contra2 ception’ means a drug, drug regimen, or device that is— 

3 ‘‘(i) approved by the Food and Drug Adminis4 tration to prevent pregnancy; and 

5 ‘‘(ii) used postcoitally.’’. 

Æ 


erowe on DSK5CLS3C1PROD with BILLS
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 548 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  2d Session
S. RES. 548

 Amending the Standing Rules of the Senate to enable the participation 
              of absent Senators during a national crisis.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 19, 2020

   Mr. Portman (for himself and Mr. Durbin) submitted the following 
     resolution; which was referred to the Committee on Rules and 
                             Administration

_______________________________________________________________________

                               RESOLUTION

 
 Amending the Standing Rules of the Senate to enable the participation 
              of absent Senators during a national crisis.

    Resolved, That

SECTION 1. PARTICIPATION OF ABSENT SENATORS DURING A NATIONAL CRISIS.

     Rule XII of the Standing Rules of the Senate is amended by adding 
at the end the following:
            ``5. Senators may use technology that has been approved by 
        the Secretary of the Senate and Sergeant at Arms and Director 
        of the Doorkeepers as reliable and secure to cast their votes 
        from outside of the Senate Chamber if the majority leader or 
        his or her designee and the minority leader or his or her 
        designee determine that an extraordinary crisis of national 
        extent exists in which it would be infeasible for Senators to 
        cast their votes in person. Senators in such circumstance may 
        then cast votes under this paragraph only during the 30-day 
        period beginning on the date on which such determination is 
        made unless such period is renewed by an affirmative vote of 
        three-fifths of the Senators duly chosen and sworn. During such 
        period, Senators participating remotely and using approved 
        technology to cast their votes under this paragraph shall be 
        deemed present for quorum purposes. The determination made 
        under this paragraph shall not rely on any decision of any 
        other branch of the United States Government. The majority 
        leader or his or her designee and the minority leader or his or 
        her designee shall submit at the beginning of the first session 
        of each Congress an order for designees of each caucus in the 
        case of such a crisis.''.
                                 <all>
```
III 

116TH CONGRESS 

2D SESSION S. RES. 522 

Electing Robert M. Duncan, of the District of Columbia, as Secretary for 

the Majority of the Senate. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 27, 2020 

Mr. MCCONNELL submitted the following resolution; which was considered 

and agreed to 

RESOLUTION 

Electing Robert M. Duncan, of the District of Columbia, 

as Secretary for the Majority of the Senate. 

1 Resolved, That Robert M. Duncan of the District of 

2 Columbia be, and he is hereby, elected Secretary for the 

3 Majority of the Senate. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF OHIO
WESTERN DIVISION
Wendy Mulyca,
Plaintiff(s),
Case Number: 1:18cv222
VS.
Chief Judge Susan J. Dlott
Commissioner of Social Security,
Defendant(s).
ORDER
The Court has reviewed the Report and Recommendation of United States Magistrate
Judge Karen L. Litkovitz filed on August 8, 2019 (Doe. 13), to whom this case was referred
pursuant to 28 U.S.C. §636(b), and noting that no objections have been filed thereto and that the
time for filing such objections under Fed. R. Civ. P. 72(b) expired August 22, 2019, hereby
ADOPTS said Report and Recommendation.
Accordingly, the decision of the Commissioner is AFFIRMED. This case is hereby

TERMINATED from the docket of this Court.

IT IS SO ORDERED.

Ketan I. Mgt

Judge Susan J. Glott
United States District Court
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 06-1460
DANIEL S. O’SHEA, Plaintiff - Appellant, versus LOCAL UNION NO. 639, International Brotherhood of Teamsters; UNITED PARCEL SERVICE, INCORPORATED, Defendants - Appellees. Appeal from the United States District Court for the District of Maryland, at Greenbelt. J. Frederick Motz, District Judge. (8:05-cv-00937-JFM) Submitted: December 14, 2006 Decided: December 18, 2006 Before MICHAEL, GREGORY, and SHEDD, Circuit Judges. Affirmed by unpublished per curiam opinion. Daniel S. O’Shea, Appellant Pro Se. Mark J. Murphy, MOONEY, GREEN, BAKER & SAINDON, Washington, D.C.; Richard J. Hafets, DLA PIPER RUDNICK GRAY CARY US LLP, Baltimore, Maryland, for Appellees. Unpublished opinions are not binding precedent in this circuit.- 2 - PER CURIAM: Daniel S. O’Shea appeals the district court’s order granting summary judgment to the Defendants in his civil action. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. O’Shea v. Local Union No. 639 , No. 8:05-cv-00937-JFM (D. Md. Aug. 4, 2006) We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
| Exhibit 32.1CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO                              SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Palomar Medical Technologies, Inc. (the “Company”) onForm 10-Q for the period ended March 31, 2008 as filed with the Securities and Exchange Commission (the“Report”), I, Joseph P. Caruso, and I, Paul S. Weiner certify, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to our knowledge:     (1)    
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities      Exchange Act of 1934; and
     (2)    
The information contained in the Report fairly presents, in all material respects, the      financial condition and results of operations of the Company.

        A signed original of this written statement required by Section 906 has been provided to theCompany and will be retained by the Company and furnished to the Securities and Exchange Commission orits Staff upon request.Dated: May 8, 2008      By:   /s/ Joseph P. Caruso         Joseph P. Caruso President and Chief Executive Officer    Dated: May 8, 2008      By:   /s/ Paul S. Weiner         Paul S. Weiner Chief Financial Officer    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
STANLEY FURNITURE COMPANY, INC.
ARTICLE 5
FINANCIAL DATA SCHEDULE
FOR PERIOD ENDING DECEMBER 31, 1997
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                             756
<SECURITIES>                                         0
<RECEIVABLES>                                    27427
<ALLOWANCES>                                      1895
<INVENTORY>                                      45730
<CURRENT-ASSETS>                                 76254
<PP&E>                                           51714
<DEPRECIATION>                                    5000
<TOTAL-ASSETS>                                  143225
<CURRENT-LIABILITIES>                            34814
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            68
<OTHER-SE>                                       48179
<TOTAL-LIABILITY-AND-EQUITY>                    143225
<SALES>                                         211905
<TOTAL-REVENUES>                                211905
<CGS>                                           159453
<TOTAL-COSTS>                                   189402
<OTHER-EXPENSES>                                   276
<LOSS-PROVISION>                                    20
<INTEREST-EXPENSE>                                3538
<INCOME-PRETAX>                                  18689
<INCOME-TAX>                                      7102
<INCOME-CONTINUING>                              11587
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     11587
<EPS-PRIMARY>                                     2.76
<EPS-DILUTED>                                     2.50
        

</TABLE>
**Exhibit 32**

 

**CERTIFICATIONSPURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

**ChiefExecutive Officer Certification**

 

Thecertification set forth below is being submitted in connection with AmendmentNo. 1 to the Form 10-Q (the “Report”) for the purpose of complying with Rule13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the“Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United StatesCode.

 

R. JackDeCrane, the Chief Executive Officer and Richard J. Kaplan, the Chief FinancialOfficer of DeCrane Aircraft Holdings, Inc., each certifies that, to the best ofhis knowledge:

 

1.                                       theReport fully complies with the requirements of Section 13(a) or 15(d) of theExchange Act; and

 

2.                                     theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of DeCrane Aircraft Holdings,Inc.

 

Date: October 9, 2003

 

 
|   | /s/  R. JACK DECRANE                        |
|--------|--------------------------------------------------|
|   | R. Jack  DeCrane                                 |
|   | Chief  Executive Officer                         |
|   |                                             |
|   |                                             |
|   | /s/  RICHARD J. KAPLAN                      |
|   | Richard J.  Kaplan                               |
|   | Senior Vice  President, Chief Financial Officer, |
|   | Secretary  and Treasurer                         |

 

----